| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0753-3322(97)89430-9 |
| P698 | PubMed publication ID | 9452787 |
| P2093 | author name string | Otto M | |
| Weber T | |||
| Zerr I | |||
| Bodemer M | |||
| P2860 | cites work | Marked increase in cerebrospinal fluid ubiquitin in Creutzfeldt-Jakob disease | Q28212266 |
| Human prion protein cDNA: molecular cloning, chromosomal mapping, and biological implications | Q28287513 | ||
| Novel proteinaceous infectious particles cause scrapie | Q29547678 | ||
| Creutzfeldt-Jakob disease with congophilic kuru plaques: CT and pathological findings of the cerebral white matter | Q33591493 | ||
| Computed tomography findings in 15 cases of Creutzfeldt-Jakob disease with histological verification | Q33620493 | ||
| Does the agent of scrapie replicate without nucleic acid? | Q34224970 | ||
| Self-replication and scrapie | Q34225002 | ||
| A new variant of Creutzfeldt-Jakob disease in the UK. | Q34374893 | ||
| Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. | Q34403513 | ||
| A cellular gene encodes scrapie PrP 27-30 protein | Q34557641 | ||
| 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins | Q35624026 | ||
| Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases | Q36838448 | ||
| BSE: a decade on--Part I. | Q36849321 | ||
| Genetics and biochemistry of Creutzfeldt-Jakob disease in Libyan Jews | Q39014767 | ||
| 14-3-3 proteins. Hot numbers in signal transduction | Q40521393 | ||
| Epidemiology of Creutzfeldt-Jakob disease | Q40730013 | ||
| Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies | Q40985315 | ||
| Creutzfeldt-Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering | Q41015587 | ||
| Clinical implications of nucleic acid amplification methods for the diagnosis of viral infections of the nervous system | Q41106962 | ||
| BSE: a decade on--Part 2. | Q41392218 | ||
| Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease | Q42630507 | ||
| Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Magnetic resonance imaging is not a sensitive test for Creutzfeldt-Jakob disease | Q43187657 | ||
| Early evolution and incidence of electroencephalographic abnormalities in Creutzfeldt-Jakob disease | Q43860274 | ||
| MR imaging of Creutzfeldt-Jakob disease | Q44637990 | ||
| Serial computed tomographic and electroencephalographic studies in Creutzfeldt-Jakob disease | Q44986599 | ||
| Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. | Q45962479 | ||
| Spontaneous neurodegeneration in transgenic mice with mutant prion protein | Q46249938 | ||
| Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease | Q48126727 | ||
| High neuron-specific enolase level of cerebrospinal fluid in the early stage of Creutzfeldt-Jakob disease | Q48219909 | ||
| Early MRI findings in Creutzfeldt-Jakob disease. | Q48251976 | ||
| High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease | Q48419470 | ||
| Focal involvement and lateralization in Creutzfeldt-Jakob disease: correlation of clinical, electroencephalographic and neuropathological findings | Q48573132 | ||
| The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies | Q48913771 | ||
| Neuro-immune connection in spread of prions in the body? | Q57083714 | ||
| Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy | Q57093007 | ||
| Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid | Q57274061 | ||
| Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease | Q57781094 | ||
| Cerebrospinal-fluid test for new-variant Creutzfeldt-Jakob disease | Q59691968 | ||
| Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. | Q64960210 | ||
| Detection of neuron specific enolase concentrations in cerebrospinal fluid from patients with neurological disorders by means of a sensitive enzyme immunoassay | Q68737436 | ||
| Computed tomography during Creutzfeldt-Jakob disease | Q69910293 | ||
| Clinical relevance of increased neuron-specific enolase concentration in cerebrospinal fluid | Q70220363 | ||
| Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases | Q70292648 | ||
| EEG findings in Creutzfeldt-Jakob disease | Q70746490 | ||
| PrP27-30 is a normal soluble prion protein fragment released by human platelets | Q71209915 | ||
| Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease | Q72318725 | ||
| Incidence of Creutzfeldt-Jakob disease in Europe in 1993 | Q72673272 | ||
| Reporting of suspect new variant Creutzfeldt-Jakob disease | Q95824321 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Creutzfeldt-Jakob disease | Q49989 |
| P304 | page(s) | 381-387 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Biomedicine and Pharmacotherapy | Q15759648 |
| P1476 | title | Diagnosis of Creutzfeldt-Jakob disease and related human spongiform encephalopathies | |
| P478 | volume | 51 |
| Q38024792 | 14-3-3 proteins in neurological disorders. |
| Q30771248 | A retrospective study of Creutzfeldt-Jakob disease in Belgium |
| Q35918933 | Comparative peptidome analyses of the profiles of the peptides ranging from 1-10 KD in CSF samples pooled from probable sporadic CJD and non-CJD patients |
| Q44494777 | Creutzfeldt-Jakob disease via dural and corneal transplants |
| Q35892062 | Diagnosing prion diseases: needs, challenges and hopes |
| Q44386883 | Evaluation of virus and prion reduction in a new intravenous immunoglobulin manufacturing process |
| Q42252580 | Global protein differential expression profiling of cerebrospinal fluid samples pooled from Chinese sporadic CJD and non-CJD patients |
| Q24548866 | Increased levels of epsilon and gamma isoforms of 14-3-3 proteins in cerebrospinal fluid in patients with Creutzfeldt-Jakob disease |
| Q34038310 | Novel approaches in diagnosis and therapy of Creutzfeldt-Jakob disease |
| Q34202007 | Pathogenesis of prion diseases: a progress report |
| Q34361504 | Pathogenesis of prion diseases: possible implications of microglial cells |
| Q41830667 | PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2. |
| Q33637729 | Prion diseases--an evidence-based protocol for infection control |
| Q38274835 | Protein misfolding cyclic amplification (PMCA): Current status and future directions. |
| Q36626077 | Protein misfolding cyclic amplification for diagnosis and prion propagation studies |
| Q33649832 | The prepared tau exon-specific antibodies revealed distinct profiles of tau in CSF of the patients with Creutzfeldt-Jakob disease |
| Q36319802 | The risk of transmission of variant Creutzfeldt-Jakob disease via contact lenses and ophthalmic devices |
Search more.